↓ Skip to main content

Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection

Overview of attention for article published in Infectious Diseases and Therapy, December 2014
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#48 of 224)
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
7 tweeters

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
25 Mendeley
Title
Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection
Published in
Infectious Diseases and Therapy, December 2014
DOI 10.1007/s40121-014-0050-x
Pubmed ID
Authors

Nicholas S. Britt, Molly E. Steed, Emily M. Potter, Lisa A. Clough

Abstract

Clostridium difficile infection (CDI) is a common cause of nosocomial diarrhea. Metronidazole and vancomycin are the primary treatment options for CDI, but increasing rates of antimicrobial resistance and severe, refractory disease have prompted the need for alternative agents. Tigecycline has previously demonstrated favorable in vitro activity against C. difficile isolates, but clinical data on its use in the treatment of CDI are severely lacking. The objective of this study was to describe our experience using tigecycline in the treatment of severe and severe complicated CDI.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 4%
Unknown 24 96%

Demographic breakdown

Readers by professional status Count As %
Professor > Associate Professor 6 24%
Other 4 16%
Student > Master 4 16%
Researcher 3 12%
Professor 2 8%
Other 6 24%
Readers by discipline Count As %
Medicine and Dentistry 13 52%
Unspecified 4 16%
Immunology and Microbiology 3 12%
Biochemistry, Genetics and Molecular Biology 1 4%
Nursing and Health Professions 1 4%
Other 3 12%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 May 2018.
All research outputs
#3,511,701
of 13,127,649 outputs
Outputs from Infectious Diseases and Therapy
#48
of 224 outputs
Outputs of similar age
#71,775
of 294,839 outputs
Outputs of similar age from Infectious Diseases and Therapy
#1
of 10 outputs
Altmetric has tracked 13,127,649 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 224 research outputs from this source. They receive a mean Attention Score of 3.4. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 294,839 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them